We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02423343
Brief Title: A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular Carcinoma

First Submitted : April 17, 2015
First Submitted that Met QC Criteria : April 17, 2015
First Posted : April 22, 2015 (Estimate)

Results First Submitted : July 2, 2021
Results First Submitted that Met QC Criteria : August 13, 2021
Results First Posted : September 9, 2021

Certification/Extension First Submitted : December 7, 2019
Certification/Extension First Submitted that Met QC Criteria : December 7, 2019
Certification/Extension First Posted : December 10, 2019

Last Update Submitted that Met QC Criteria : August 13, 2021
Last Update Posted : September 9, 2021